Chargement en cours...
Potential Pitfalls of Crossover and Thoughts on Iniparib in Triple-Negative Breast Cancer
As recruitment for oncology clinical trials has become more difficult, there appears to have been an increase in the number of studies that allow patients in the control arm to “crossover” and receive the experimental therapy after disease progression. Although some researchers worry that allowing s...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Oxford University Press
2011
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3247787/ https://ncbi.nlm.nih.gov/pubmed/22045362 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djr386 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|